Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Assessment of Conduit-Assisted Primary Nerve Repair Strength With Varying Suture Size, Number, and Location.

Babovic N, Klaus D, Schessler MJ, Schimoler PJ, Kharlamov A, Miller MC, Tang P.

Hand (N Y). 2018 Apr 1:1558944718769382. doi: 10.1177/1558944718769382. [Epub ahead of print]

PMID:
29619886
2.

Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines.

Konjevic G, Vuletic A, Mirjacic Martinovic K, Krivokuca A, Jankovic R, Babovic N.

J Membr Biol. 2017 Oct;250(5):507-516. doi: 10.1007/s00232-017-9977-7. Epub 2017 Sep 8.

PMID:
28887642
3.

The Effect of Metacarpophalangeal Joint Hyperextension on Outcomes in the Surgical Treatment of Carpometacarpal Joint Arthritis.

Brogan DM, van Hogezand RM, Babovic N, Carlsen B, Kakar S.

J Wrist Surg. 2017 Aug;6(3):188-193. doi: 10.1055/s-0036-1597836. Epub 2016 Dec 28.

PMID:
28725499
4.

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.

Kandolf Sekulovic L, Peris K, Hauschild A, Stratigos A, Grob JJ, Nathan P, Dummer R, Forsea AM, Hoeller C, Gogas H, Demidov L, Lebbe C, Blank C, Olah J, Bastholt L, Herceg D, Neyns B, Vieira R, Hansson J, Rutkowski P, Krajsova I, Bylaite-Bucinskiene M, Zalaudek I, Maric-Brozic J, Babovic N, Banjin M, Putnik K, Weinlich G, Todorovic V, Kirov K, Ocvirk J, Zhukavets A, Kukushkina M, De La Cruz Merino L, Ymeri A, Risteski M, Garbe C.

Eur J Cancer. 2017 Apr;75:313-322. doi: 10.1016/j.ejca.2017.01.012. Epub 2017 Mar 4.

PMID:
28264791
5.
6.

Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma.

Mirjačić Martinović K, Srdić-Rajić T, Babović N, Džodić R, Jurišić V, Konjević G.

J Clin Pathol. 2016 Apr;69(4):300-6. doi: 10.1136/jclinpath-2015-203107. Epub 2015 Oct 6.

PMID:
26442832
7.

Clinicopathological characteristics, diagnosis and treatment of melanoma in Serbia--the Melanoma Focus Study.

Kandolf-Sekulović L, Babović N, Jokić N, Nikolin B, Nikolić D, Janjić Z, Mijugković Z, Rajović M, Novaković M, Pejcić I, Kovaević P, Mihajlović D, Roganović T, Ferenc V, Nikolić J, Marinković M, Bizetić Z.

Vojnosanit Pregl. 2015 Apr;72(4):312-6.

PMID:
26040176
8.

Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.

Mirjačić Martinović K, Babović N, Džodić R, Jurišić V, Matković S, Konjević G.

J Transl Med. 2015 Apr 14;13:120. doi: 10.1186/s12967-015-0479-z.

9.

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial.

Blay JY, Pápai Z, Tolcher AW, Italiano A, Cupissol D, López-Pousa A, Chawla SP, Bompas E, Babovic N, Penel N, Isambert N, Staddon AP, Saâda-Bouzid E, Santoro A, Franke FA, Cohen P, Le-Guennec S, Demetri GD.

Lancet Oncol. 2015 May;16(5):531-40. doi: 10.1016/S1470-2045(15)70102-6. Epub 2015 Apr 8.

PMID:
25864104
10.

Use of Extracorporeal Membrane Oxygenation to Stabilize a Polytrauma Patient During Intramedullary Nailing of a Femoral Fracture: A Case Report.

Chauhan A, Babovic N, Moraca RJ, Altman DT.

JBJS Case Connect. 2014 Oct/Dec/Nov;4(4):e112. doi: 10.2106/JBJS.CC.N.00029.

PMID:
29252780
11.

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.

Mirjačić Martinović KM, Babović NLj, Džodić RR, Jurišić VB, Tanić NT, Konjević GM.

Melanoma Res. 2014 Aug;24(4):295-304. doi: 10.1097/CMR.0000000000000072.

PMID:
24769842
12.

Cat bite infections of the hand: assessment of morbidity and predictors of severe infection.

Babovic N, Cayci C, Carlsen BT.

J Hand Surg Am. 2014 Feb;39(2):286-90. doi: 10.1016/j.jhsa.2013.11.003.

PMID:
24480688
13.

Total hip arthroplasty using highly cross-linked polyethylene in patients younger than 50 years with minimum 10-year follow-up.

Babovic N, Trousdale RT.

J Arthroplasty. 2013 May;28(5):815-7. doi: 10.1016/j.arth.2012.12.005. Epub 2013 Mar 15.

PMID:
23499405
15.

Allergic reactions during anesthesia at a large United States referral center.

Gurrieri C, Weingarten TN, Martin DP, Babovic N, Narr BJ, Sprung J, Volcheck GW.

Anesth Analg. 2011 Nov;113(5):1202-12. doi: 10.1213/ANE.0b013e31822d45ac. Epub 2011 Aug 24.

PMID:
21865494
16.

In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.

Konjević G, Mirjačić Martinović K, Vuletić A, Babović N.

Melanoma Res. 2010 Dec;20(6):459-67. doi: 10.1097/CMR.0b013e32833e3286.

PMID:
20938360
17.

The stage dependent changes in NK cell activity and the expression of activating and inhibitory NK cell receptors in melanoma patients.

Mirjačić Martinović K, Konjević G, Babović N, Inić M.

J Surg Res. 2011 Dec;171(2):637-49. doi: 10.1016/j.jss.2010.05.012. Epub 2010 Jun 8.

PMID:
20828749
18.

Mucinous cystadenoma of ovary in a patient with juvenile polyposis due to 10q23 microdeletion: expansion of phenotype.

Babovic N, Simmons PS, Moir C, Thorland EC, Scheithauer B, Gliem TJ, Babovic-Vuksanovic D.

Am J Med Genet A. 2010 Oct;152A(10):2623-7. doi: 10.1002/ajmg.a.33637.

PMID:
20815035
19.

Vitamin A deficiency in an infant with PAGOD syndrome.

Gavrilova R, Babovic N, Lteif A, Eidem B, Kirmani S, Olson T, Babovic-Vuksanovic D.

Am J Med Genet A. 2009 Oct;149A(10):2241-7. doi: 10.1002/ajmg.a.32998.

PMID:
19760653
20.

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.

Konjević G, Mirjacić Martinović K, Jurisić V, Babović N, Spuzić I.

Biomarkers. 2009 Jun;14(4):258-70. doi: 10.1080/13547500902814658.

PMID:
19489688
21.

Molecular targeting agents in renal cell carcinoma: present strategies and future perspectives.

Bjelogrlic SK, Radulovic S, Babovic N.

Curr Pharm Des. 2008;14(11):1058-77. Review.

PMID:
18473855
22.

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.

Konjević G, Mirjacić Martinović K, Vuletić A, Jović V, Jurisić V, Babović N, Spuzić I.

Clin Exp Metastasis. 2007;24(1):1-11. Epub 2007 Feb 13.

PMID:
17295095
23.

Phase II trial of pirfenidone in adults with neurofibromatosis type 1.

Babovic-Vuksanovic D, Ballman K, Michels V, McGrann P, Lindor N, King B, Camp J, Micic V, Babovic N, Carrero X, Spinner R, O'Neill B.

Neurology. 2006 Nov 28;67(10):1860-2. Epub 2006 Oct 11.

PMID:
17035676
24.

Antimelanoma immunity in vitiligo and melanoma patients.

Juranic ZD, Stanojevic-Bakic N, Zizak Z, Babovic N, Radovic-Kovacevic V, Stanojkovic T, Dzodic R.

Neoplasma. 2003;50(4):305-9.

PMID:
12937846
25.

Use of high-dose cytarabine to enhance cisplatin cytotoxicity-effects on the response and overall survival rates of advanced head and neck cancer patients.

Jelić S, Stamatović Lj, Vucićević S, Petrović Z, Kreacić M, Babović N, Jovanović N, Mikić A, Gavrilović D.

Eur J Cancer. 2002 Jul;38(11):1478-89.

PMID:
12110494
26.

Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures: a single-center study.

Jelić S, Babović N, Stamatović L, Kreacić M, Matković S, Popov I.

Med Oncol. 2001;18(3):189-95.

PMID:
11917943
27.

Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study.

Jelić S, Babovic N, Kovcin V, Milicevic N, Milanovic N, Popov I, Radosavljevic D.

Melanoma Res. 2002 Feb;12(1):91-8.

PMID:
11828263
28.

Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study.

Jelić S, Mitrović L, Radosavljević D, Elezar E, Babović N, Kovcin V, Tomasević Z, Kovacević S, Gavrilović D, Radulović S.

Lung Cancer. 2001 Oct;34(1):1-13.

PMID:
11557107
29.

[Systemic therapy in carcinoma of the renal parenchyma].

Babović N, Popov I, Kreacić M, Jelić S.

Srp Arh Celok Lek. 2001 Jan-Feb;129(1-2):29-32. Review. Serbian. No abstract available.

PMID:
11534281
30.

[Therapy of metastatic melanoma].

Babović N, Jelić S, Popov I.

Srp Arh Celok Lek. 2000 Jul-Aug;128(7-8):284-9. Review. Serbian. No abstract available.

PMID:
11089438
31.

Primary non-Hodgkin lymphoma of the breast. Is it possible to avoid mastectomy?

Babovic N, Jelic S, Jovanovic V.

J Exp Clin Cancer Res. 2000 Jun;19(2):149-54.

PMID:
10965810
32.

Epirubicin 150 mg/m2-cisplatin versus epirubicin 180 mg/m2-cisplatin for advanced soft tissue sarcoma.

Jelić S, Babović N, Kreacić M, Matković S, Milanović N, Gavrilović D, Tomasević Z.

Int J Clin Pharmacol Res. 1999;19(4):129-38.

PMID:
10939030
33.

[Chemotherapy of carcinoma of the germinal epithelium of the testis].

Babović N, Popov I, Stamatović Lj, Jelić S.

Srp Arh Celok Lek. 2000 Mar-Apr;128(3-4):124-9. Review. Serbian. No abstract available.

PMID:
10932623
34.

[Drug therapy of hormone-dependent tumors].

Jelić S, Popov I, Colaković S, Lukić V, Radosavljević D, Babović N, Kreacić M.

Srp Arh Celok Lek. 1999 Jan-Feb;127(1-2):54-64. Review. Serbian. No abstract available.

PMID:
10377842
35.
36.

[Levels of immune complexes in fresh and frozen serum and plasma detected by precipitation with polyethylene glycol in patients with malignant diseases].

Kovcin V, Juranić Z, Babović N, Tomasević Z.

Srp Arh Celok Lek. 1997 May-Jun;125(5-6):154-6. Serbian.

PMID:
9265236
37.
38.

Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.

Jelić S, Kovcin V, Milanović N, Babović N, Kreacić M, Ristović Z, Vlajić M, Filipović-Ljesković I.

Eur J Cancer. 1997 Feb;33(2):220-5.

PMID:
9135492
39.

[Anti-pain effect of salmon calcitonin in bone metastases of malignant tumors with the exception of breast and prostatic carcinoma].

Jelić S, Borkovacki R, Babović N, Kovcin V, Milanović N.

Vojnosanit Pregl. 1995 Mar-Apr;52(2):151-4. Serbian.

PMID:
7571528
40.

[Carcinoembryonal antigen (CEA) in malignant lymphomas].

Kovcin V, Jelić S, Babović N.

Srp Arh Celok Lek. 1994 May-Jun;122(5-6):168-70. Serbian.

PMID:
17977419
41.

A pilot study to assess the efficacy of salmon calcitonin in the relief of neuropathic pain caused by extraskeletal metastases.

Kovcin V, Jelić S, Babović N, Tomasević Z.

Support Care Cancer. 1994 Jan;2(1):71-3.

PMID:
8156261
42.

Supplemental Content

Loading ...
Support Center